Print

Lay Description

We will assess physical functioning, daily physical activity with wearable activity monitors, biological markers (serum and salivary cortisol), diet, program adherence, as well as psycho-social measures of physical, mental, and spiritual wellbeing. In addition, BCS will be asked to describe their best day possible and their typical day. We will conduct a qualitative analysis from their responses to identify endorsement of themes.

Category

  • Cancers and Other Neoplasms
  • Breast - Female
IRB Number
20220300HU
NCT Number
ct.gov registration not required
Open to Enrollment
Yes

Eligibility

Eligible Ages
>18
Eligible Genders
Female
Accepts Healthy Volunteers

Inclusion Criteria

1. Adults, age greater than 18 years

2. Have been given a diagnosis of breast cancer in their lifetime:

• Must be post diagnosis

• May be on active treatment or post treatment

3. Have access to a “SMART” device (mobile phone) with internet access to download the BlueJay application to complete questionnaires, respond to app messaging, and watch recorded intervention videos and/or livestream sessions.

4. Be able to speak and understand English or Spanish at the 8th grade level or higher.

5. Able to travel to the UT Health campus at least twice over the 6 months.

6. Oriented to time and place

7. COVID-19 vaccination

Exclusion Criteria

1. They present with any cognitive impairment that limits their ability to understand and provide informed consent, or to comply with the protocol procedures.

2. Are currently enrolled in a competing biobehavioral intervention protocol.

3. Currently in an active yoga program (>weekly classes/practice) for the past 3 months

4. Currently in an active meditation practice, any type > weekly, for the past 3 months

5. Present with any absolute contraindication to exercise testing as detailed by the

American College of Sports Medicine Guidelines on Exercise Testing and

Exercise Prescription. Specifically:

 Known significant change in the resting ECG, suggesting significant ischemia.

 Recent myocardial infarction (within 2 days).

 Unstable angina.

 Uncontrolled cardiac arrhythmias causing symptoms or hemodynamic compromise.

 Severe symptomatic aortic stenosis.

 Uncontrolled symptomatic heart failure.

 Acute pulmonary embolus or pulmonary infarction.

 Acute myocarditis or pericarditis.

 Suspected or known dissecting aneurysm.

Study Design

Arm Groups

Study Contact


Regulatory Point of Contact
Frances Crawford
(210) 450-5037
crawfordf1@uthscsa.edu

Regulatory Point of Contact
Sonia Creighton
(210) 450-1366
creighton@uthscsa.edu

Regulatory Point of Contact
Daniel Hughes
(210) 562-6506
hughesdc@uthscsa.edu

Regulatory Point of Contact
Myrna Montenegro
(210) 450-5954
montenegro@uthscsa.edu

Regulatory Point of Contact
Amelie Ramirez
(210) 562-6500
ramirezag@uthscsa.edu

Regulatory Point of Contact
Mailbox Ctrc Regulatory Affairs
regaffapp@uthscsa.edu

Regulatory Point of Contact
Kathleen Rodriguez
(210) 450-1365
rodriguezk3@uthscsa.edu

Regulatory Point of Contact
Benjamin Schleif
(210) 450-1366
schleifb@uthscsa.edu

Regulatory Point of Contact
Morgan Seekatz
(210) 450-1133
seekatz@uthscsa.edu

Overall Recruitment Point of Contact
Daniel Hughes
(210) 562-6506
hughesdc@uthscsa.edu

Overall Recruitment Point of Contact
Amelie Ramirez
(210) 562-6500
ramirezag@uthscsa.edu

Principal Investigator
Amelie Ramirez